Literature DB >> 32071904

Management of Hepatocellular Carcinoma in Japan: Current Trends.

Masatoshi Kudo1.   

Abstract

Year:  2019        PMID： 32071904      PMCID： PMC7024863          DOI： 10.1159/000505370

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  5 in total

1.  Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future.

Authors:  Devanand Sarkar
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

Review 2.  Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?

Authors:  Ti Zhang; Philippe Merle; Huaqi Wang; Haitao Zhao; Masatoshi Kudo
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 8.265

3.  Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.

Authors:  Shigeo Shimose; Hideki Iwamoto; Masatoshi Tanaka; Takashi Niizeki; Masahiko Kajiwara; Satoshi Itano; Etsuko Moriyama; Tomotake Shirono; Yu Noda; Naoki Kamachi; Masahito Nakano; Ryoko Kuromatsu; Hironori Koga; Takumi Kawaguchi
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

4.  Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response.

Authors:  Yasunori Minami; Tomoko Aoki; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Hiroshi Ida; Kazuomi Ueshima; Naoshi Nishida; Masatoshi Kudo
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

5.  Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.

Authors:  Atsushi Hiraoka; Takashi Kumada; Kazuya Kariyama; Toshifumi Tada; Joji Tani; Shinya Fukunishi; Masanori Atsukawa; Masashi Hirooka; Kunihiko Tsuji; Toru Ishikawa; Koichi Takaguchi; Ei Itobayashi; Kazuto Tajiri; Noritomo Shimada; Hiroshi Shibata; Hironori Ochi; Kazuhito Kawata; Satoshi Yasuda; Hidenori Toyoda; Hideko Ohama; Kazuhiro Nouso; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Korenobu Hayama; Taeang Arai; Michitaka Imai; Yohei Koizumi; Shinichiro Nakamura; Kouji Joko; Kojiro Michitaka; Yoichi Hiasa; Masatoshi Kudo
Journal:  J Gastroenterol Hepatol       Date:  2020-11-29       Impact factor: 4.029
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.